Intestinal permeability before and after ibuprofen in families of children with Crohn's disease

被引:25
|
作者
Zamora, SA [1 ]
Hilsden, RJ [1 ]
Meddings, JB [1 ]
Butzner, JD [1 ]
Scott, RB [1 ]
Sutherland, LR [1 ]
机构
[1] Univ Calgary, Hlth Sci Ctr, Dept Pediat, Calgary, AB T2N 4N1, Canada
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY | 1999年 / 13卷 / 01期
关键词
Crohn's disease; inflammatory bowel disease; intestinal permeability; nonsteroidal anti-inflammatory drugs (NSAIDs);
D O I
10.1155/1999/457315
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Members of a subset of first:degree relatives of adults with Crohn's disease have been shown to have an increased baseline intestinal permeability and/or an exaggerated increase in intestinal permeability after the administration of acetylsalicylic acid. PURPOSE: To determine intestinal permeability in unaffected first-degree relatives of children with Crohn's disease before and after the administration of an ibuprofen challenge. METHODS: Lactulose-mannitol ratios, a measure of intestinal permeability, were determined in 14 healthy control families (41 subjects) and 14 families with a child with Crohn's disease (36 relatives, 14 probands) before and after ingestion of ibuprofen. An upper reference limit was defined using the control group as mean +/- 2 SD. RESULTS: The proportion of healthy, first-degree relatives with an exaggerated response to ibuprofen (20%, 95% CI 7% to 33%) was significantly higher than controls (P=0.003). The exaggerated response was more common among siblings than among parents of pediatric probands. CONCLUSIONS: Members of a subset of first degree relatives of children with Crohn's disease have an exaggerated increase in intestinal permeability after ibuprofen ingestion. These findings are compatible with there being a genetic link between abnormalities of intestinal permeability and Crohn's disease.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [1] Intestinal permeability (IP) before and after ibuprofen in families of children with Crohn's disease.
    Zamora, SA
    Scott, RB
    Butzner, DJ
    Hilsden, RJ
    Meddings, JB
    Sutherland, LR
    GASTROENTEROLOGY, 1997, 112 (04) : A1127 - A1127
  • [2] Clustering of increased small intestinal permeability in families with Crohn's disease
    Peeters, M
    Geypens, B
    Claus, D
    Nevens, H
    Ghoos, Y
    Verbeke, G
    Baert, F
    Vermeire, S
    Vlietinck, R
    Rutgeerts, P
    GASTROENTEROLOGY, 1997, 113 (03) : 802 - 807
  • [3] Intestinal permeability in Crohn's disease
    Franchimont, D
    Louis, E
    Simon, S
    Belaiche, J
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1996, 59 (01): : 15 - 19
  • [4] Intestinal permeability in Crohn's disease
    Meddings, JB
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 : 47 - 53
  • [5] Intestinal permeability in Crohn's disease
    Meddings, JB
    TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 29 - 38
  • [6] Intestinal permeability in patients with Crohn's disease
    Benjamin, Jaya
    Makharia, Govind K.
    Ahuja, Vineet
    Kalaivani, M.
    Joshi, Yogendra K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A418 - A418
  • [7] Intestinal permeability in Crohn's disease - Discussion
    Sartor, RB
    Meddings, J
    Mayer, L
    Kraehenbuhl, JP
    Brandtzaeg, P
    Jewell, D
    Bjarnason, L
    Madara, J
    Feagan, B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 : 53 - 56
  • [8] Glutamine supplementation and intestinal permeability in Crohn's disease
    Akobeng, AK
    Miller, V
    Thomas, AG
    Richmond, K
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2000, 24 (03) : 196 - 196
  • [10] Abnormal intestinal permeability in Crohn's disease pathogenesis
    Teshima, Christopher W.
    Dieleman, Levinus A.
    Meddings, Jon B.
    BARRIERS AND CHANNELS FORMED BY TIGHT JUNCTION PROTEINS II, 2012, 1258 : 159 - 165